glp-1 news today food industry GLP‑1 trends: What manufacturers must do next GLP-1 Weight Loss Pills Could

Brazilian regulator ANVISA has received at least 4 requests to licence generic semaglutide

Those with cancer history, pregnancy, or serious medical conditions should consult healthcare providers before use

By implementing point-of-sale safety alerts on duplicate therapy for glucagon-like peptide 1 (GLP-1) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors through Judi, our cloud-native enterprise health platform, we saw a meaningful reduction in the percentage of instances with day supply overlap

Use an insulated travel case with a small gel pack if your flight is long, and ensure the medication does not come into direct contact with the ice pack to avoid accidental freezing

Under the influence of an external magnetic field, therapeutic drugs or molecules can be loaded onto magnetic nanoparticles and targeted to precise regions in the body

In a research context, this solution serves as a comprehensive supplement for in vitro cell culture media